Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic Screens in Antimalarial Drug Discovery.

Trends in parasitology - 1 Sept 2016

Hovlid Marisa L, Winzeler Elizabeth A

Abstract excerpt

Phenotypic high-throughput screens are a valuable tool for identifying new chemical compounds with antimalarial activity. Traditionally, these screens have focused solely on the symptomatic asexual blood stage of the parasite life cycle; however, to discover new medicines for malaria treatment and prevention, robust screening technologies against other parasite life-cycle stages are required. This review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Plasmodium falciparum
Share to Antimalarials
Share to Drug Evaluation, Preclinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Life Cycle Stages

Share to Malaria

Share to Malaria Research and Control

Share to Mosquito-borne diseases and control

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 27247245
DOI: 10.1016/j.pt.2016.04.014
PMCID: PMC5007148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic Screens in Antimalarial Drug Discovery.PMID 27247245Read ↗

Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages.Semantic proximity Read ↗

Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of actionSemantic proximity Read ↗

Cell based assays for anti-Plasmodium activity evaluation.Semantic proximity Read ↗

Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicitySemantic proximity Read ↗

Target Identification and Validation of Novel AntimalarialsSemantic proximity Read ↗

Identification of Antimalarial Inhibitors Using Late-Stage Gametocytes in a Phenotypic Live/Dead Assay.Semantic proximity Read ↗

High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent MalariaSemantic proximity Read ↗

Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradicationSemantic proximity Read ↗

Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.Semantic proximity Read ↗

The impact of phenotypic- versus target-based approaches in antimalarial drug discovery in the last two decades (2005-2025).Semantic proximity Read ↗

Global Phenotypic Screening for AntimalarialsSemantic proximity Read ↗

Using Genetic Methods To Define the Targets of Compounds with Antimalarial ActivitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.